http://www.marketwatch.com/story/biocryst-to-present-peramivir-trial-results-for-the-treatment-of-influenza-at-the-icaac-2014-meeting-2014-09-02?reflink=MW_news_stmp
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment